(UL) Unilever - Overview
Stock: Shampoo, Soap, Deodorant, Detergent, Seasoning
| Risk 5d forecast | |
|---|---|
| Volatility | 20.7% |
| Relative Tail Risk | -5.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.97 |
| Alpha | 16.88 |
| Character TTM | |
|---|---|
| Beta | 0.024 |
| Beta Downside | -0.227 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.93% |
| CAGR/Max DD | 0.76 |
Description: UL Unilever January 27, 2026
Unilever PLC (NYSE: UL) is a global fast-moving consumer goods (FMCG) group that sells a diversified portfolio of brands across four operating segments-Beauty & Wellbeing, Personal Care, Home Care, and Foods-in more than 190 markets spanning Asia-Pacific, Africa, the Americas and Europe.
In FY 2023 the company generated €60.1 billion of underlying sales, growing 2.2% YoY on a constant-currency basis, with an operating margin of 17.5% and a net-debt-to-EBITDA ratio of 1.9×, reflecting steady cash-flow generation despite higher commodity costs. The dividend payout remained at 3.3% of the share price, underscoring a commitment to shareholder returns.
Key drivers of Unilever’s performance include: (1) inflation-adjusted consumer spending trends in emerging markets, where per-capita income growth of ~5% YoY is boosting demand for affordable personal-care and home-care products; (2) a continued shift toward sustainable and “clean-label” offerings, with the Beauty & Wellbeing segment posting a 4.1% sales premium on products certified with the company’s “Sustainable Living” label; and (3) accelerating e-commerce penetration, which now accounts for roughly 12% of total sales and is growing at 15% annually, outpacing the broader FMCG sector.
For a deeper, data-driven assessment of Unilever’s valuation relative to peers, consider exploring the analytics platform ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 15.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA -2.60 > 1.0 |
| NWC/Revenue: -4.13% < 20% (prev -6.27%; Δ 2.13% < -1%) |
| CFO/TA 0.32 > 3% & CFO 22.50b > Net Income 15.21b |
| Net Debt (24.52b) to EBITDA (19.48b): 1.26 < 3 |
| Current Ratio: 0.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.18b) vs 12m ago -13.74% < -2% |
| Gross Margin: 69.99% > 18% (prev 0.25%; Δ 6974 % > 0.5%) |
| Asset Turnover: 152.7% > 50% (prev 118.9%; Δ 33.88% > 0%) |
| Interest Coverage Ratio: 16.29 > 6 (EBITDA TTM 19.48b / Interest Expense TTM 1.04b) |
Altman Z'' -1.31
| A: -0.07 (Total Current Assets 17.07b - Total Current Liabilities 21.66b) / Total Assets 70.47b |
| B: -0.53 (Retained Earnings -37.40b / Total Assets 70.47b) |
| C: 0.23 (EBIT TTM 16.93b / Avg Total Assets 72.85b) |
| D: -0.68 (Book Value of Equity -37.31b / Total Liabilities 54.94b) |
| Altman-Z'' Score: -1.31 = CCC |
Beneish M -3.41
| DSRI: 1.20 (Receivables 7.35b/4.94b, Revenue 111.26b/89.41b) |
| GMI: 0.35 (GM 69.99% / 24.55%) |
| AQI: 0.96 (AQ_t 0.59 / AQ_t-1 0.62) |
| SGI: 1.24 (Revenue 111.26b / 89.41b) |
| TATA: -0.10 (NI 15.21b - CFO 22.50b) / TA 70.47b) |
| Beneish M-Score: -3.41 (Cap -4..+1) = AA |
What is the price of UL shares?
Over the past week, the price has changed by +2.77%, over one month by +13.96%, over three months by +10.92% and over the past year by +23.49%.
Is UL a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the UL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 76.9 | 4% |
| Analysts Target Price | 76.9 | 4% |
UL Fundamental Data Overview February 17, 2026
P/E Trailing = 24.2964
P/E Forward = 19.8413
P/S = 3.2295
P/B = 8.8368
P/EG = 2.2567
Revenue TTM = 111.26b EUR
EBIT TTM = 16.93b EUR
EBITDA TTM = 19.48b EUR
Long Term Debt = 25.70b EUR (from longTermDebt, last quarter)
Short Term Debt = 6.20b EUR (from shortTermDebt, last fiscal year)
Debt = 30.66b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 24.52b EUR (from netDebt column, last fiscal year)
Enterprise Value = 164.12b EUR (137.41b + Debt 30.66b - CCE 3.94b)
Interest Coverage Ratio = 16.29 (Ebit TTM 16.93b / Interest Expense TTM 1.04b)
EV/FCF = 17.52x (Enterprise Value 164.12b / FCF TTM 9.37b)
FCF Yield = 5.71% (FCF TTM 9.37b / Enterprise Value 164.12b)
FCF Margin = 8.42% (FCF TTM 9.37b / Revenue TTM 111.26b)
Net Margin = 13.67% (Net Income TTM 15.21b / Revenue TTM 111.26b)
Gross Margin = 69.99% ((Revenue TTM 111.26b - Cost of Revenue TTM 33.39b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 2.33 (Enterprise Value 164.12b / Total Assets 70.47b)
Interest Expense / Debt = 1.23% (Interest Expense 377.0m / Debt 30.66b)
Taxrate = 33.31% (1.20b / 3.60b)
NOPAT = 11.29b (EBIT 16.93b * (1 - 33.31%))
Current Ratio = 0.79 (Total Current Assets 17.07b / Total Current Liabilities 21.66b)
Debt / Equity = 1.97 (Debt 30.66b / totalStockholderEquity, last quarter 15.53b)
Debt / EBITDA = 1.26 (Net Debt 24.52b / EBITDA 19.48b)
Debt / FCF = 2.62 (Net Debt 24.52b / FCF TTM 9.37b)
Total Stockholder Equity = 18.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 20.88% (Net Income 15.21b / Total Assets 70.47b)
RoE = 82.65% (Net Income TTM 15.21b / Total Stockholder Equity 18.41b)
RoCE = 38.38% (EBIT 16.93b / Capital Employed (Equity 18.41b + L.T.Debt 25.70b))
RoIC = 38.81% (NOPAT 11.29b / Invested Capital 29.09b)
WACC = 5.06% (E(137.41b)/V(168.06b) * Re(6.0%) + D(30.66b)/V(168.06b) * Rd(1.23%) * (1-Tc(0.33)))
Discount Rate = 6.0% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -7.12%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈10.40b ; Y1≈12.83b ; Y5≈21.85b
Fair Price DCF = 280.1 (EV 636.40b - Net Debt 24.52b = Equity 611.88b / Shares 2.18b; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -11.90 | EPS CAGR: -61.30% | SUE: 0.0 | # QB: 0
Revenue Correlation: 6.50 | Revenue CAGR: -7.55% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=3.19 | Chg30d=+0.105 | Revisions Net=+0 | Growth EPS=+3.4% | Growth Revenue=+1.7%
EPS next Year (2027-12-31): EPS=3.41 | Chg30d=-0.114 | Revisions Net=-2 | Growth EPS=+7.0% | Growth Revenue=+3.9%